Nimustine Hydrochloride

盐酸尼莫司汀

Report date: 2022/04/07 15:22:16
NME

Base Information

Drug NameNimustine Hydrochloride
Drug Alias NameACNU盐酸尼氮芥NidranNSC-245382
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsLung NeoplasmsBrain NeoplasmsLiver Neoplasms +[9] 
Global Approved IndicationsLung NeoplasmsBrain NeoplasmsLiver Neoplasms +[9] 
Approved Indications in ChinaLung NeoplasmsBrain NeoplasmsLiver Neoplasms +[8] 
Original Approved Country/TerritoryJapan
Original Approved Date1979/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBrain NeoplasmsLiver Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeL01AD06
Related LinksWikipediaKEGG